Impact of Metabolic Testing and Education on Carbohydrate Beliefs in Young Female Athletes

Effects of Metabolic Testing Data and Education on Attitudes and Beliefs Related to Carbohydrate Intake in Adolescent Female Athletes

Not applicable Interventional PepsiCo Global R&D · NCT06837376

This study tests if giving young female athletes personalized metabolic testing along with nutrition education can change their beliefs about eating carbohydrates compared to just education alone.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment60 (estimated)
Ages13 Years to 19 Years
SexFemale
SponsorPepsiCo Global R&D Industry-sponsored
Locations1 site (Bradenton, Florida)
Trial IDNCT06837376 on ClinicalTrials.gov

What this trial studies

This study aims to evaluate how education and metabolic testing influence the attitudes and beliefs of adolescent female athletes regarding carbohydrate intake. Participants will receive either educational information alone or education combined with personalized metabolic testing results. The primary goal is to determine if the addition of metabolic testing significantly alters beliefs about carbohydrate consumption compared to education alone. The study focuses on addressing nutritional deficiencies in this demographic, which is often characterized by underconsumption of carbohydrates.

Who should consider this trial

Good fit: Ideal candidates are female athletes aged 13-19 who are currently enrolled in a sport at IMG Academy.

Not a fit: Patients who are not enrolled in a sport or are outside the age range of 13-19 may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved nutritional practices and performance outcomes for adolescent female athletes.

How similar studies have performed: While there is existing research on nutritional education, this specific approach combining metabolic testing with education is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Females aged between the ages of 13-19 years old
2. Non-smoker
3. Currently enrolled in an IMG Academy sport
4. Willing to fast overnight (10 hours) prior to testing (for metabolic testing group).
5. Understand the protocol and be able to give verbal and written informed consent for participation as well as obtain parental consent if \<18 years of age.
6. Must be fluent in English reading, writing, and speaking.
7. You are not employed by, or have a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If you are unsure if a company would be considered a competitor to Gatorade, let the study investigator know the name of the other company and the nature of your relationship to that company before you sign the informed consent
8. If subject has asthma, they may still participate in but will be required to bring their prescribed inhaler if placed in the metabolic testing group

Exclusion Criteria:

1. Expulsion from school for any reason
2. Leaving the IMG sports team
3. Pregnant or planning to become pregnant
4. Participated in any other clinical trial in the past 30 day
5. Participated in any PepsiCo trial in the past 6 months
6. Physical injury that would prevent participation in exercise group

Where this trial is running

Bradenton, Florida

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Nutritional Deficiencyexercise performancemetabolic testingeducationcarbohydrateadolescentfemaleathlete
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.